CONSUN PHARMAC.GR.HD -10 (C1P) — Net Asset Quality Index
CONSUN PHARMAC.GR.HD -10 (C1P) has a Net Asset Quality Index of 75.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €6.41 Billion minus total liabilities of €1.57 Billion yields net assets of €4.84 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read CONSUN PHARMAC.GR.HD -10 debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
CONSUN PHARMAC.GR.HD -10 Net Asset Quality Index Over Time (2021–2025)
This chart shows how CONSUN PHARMAC.GR.HD -10's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 75.5%, representing net assets of €4.84 Billion against total assets of €6.41 Billion EUR. For live market cap and overall valuation, see CONSUN PHARMAC.GR.HD -10 market cap and net worth.
Annual Net Asset Quality Index for CONSUN PHARMAC.GR.HD -10 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See C1P net asset value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.5% | €4.84 Billion | €6.41 Billion | €1.57 Billion | ▲ +0.4 pp |
| 2024 | 75.1% | €4.39 Billion | €5.85 Billion | €1.46 Billion | ▲ +3.9 pp |
| 2023 | 71.1% | €3.92 Billion | €5.51 Billion | €1.59 Billion | ▲ +0.9 pp |
| 2022 | 70.3% | €3.44 Billion | €4.89 Billion | €1.45 Billion | ▲ +3.6 pp |
| 2021 | 66.7% | €2.91 Billion | €4.36 Billion | €1.45 Billion | — |